🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Our GI rad onc family is deeply grieving the loss of our friend, colleague, and brother, Cullen Taniguchi, MD. We had the privilege of closely seeing his brilliance, kindness, warmth, and authenticity. He was a true gem whose loss has left an unfillable void in our hearts MD Anderson Cancer Center

Our article on Aeromonas spp. has been published in Open Forum Infectious Diseases. We demonstrated clinical features, molecular epidemiology, and antimicrobial resistance profiles of Aeromonas spp. causing human infections. track.smtpsendmail.com/9032119/c?p=k5…

Llevamos 5 meses sin la aprobación de COFEPRIS de un estudio de tuberculosis meníngea en personas con #VIH, financiado por el NIH de la colaboración ACTG Network. Un estudio ya aprobado por la U.S. FDA y activo en otros centros internacionales…quizá se pregunten y esto qué? 1/3

Join our ID Fellowship at Houston Methodist HMH Infectious Disease Fellowships—open general ID positions for July 2024. Level up your career with diverse clinical exposure in Texas’ top hospital! 🏥 Dive into transplant ID, advanced fellowships, and relish work-life balance. Apply now Miller Lab Group

Congratulations to our Dimitrios Kontoyiannis @MDAndersonsnews on receiving the 2023-24 American College of Physicians Harriet P. Dustan Award for his outstanding contributions to Medicine ACP

#idtwitter check out our faculty Dr Pritchard ⁦@Strongylady⁩ moderating ⁦SHEA⁩ podcast on PCN allergies and Stewardship considerations: podcasts.apple.com/us/podcast/she…

The field of infectious diseases (ID) is broad and involves many organ systems. An ID rotation guide from @NEJMres360, which is free for the month of December, focuses on some key areas. Access the free guide now: nej.md/41fYFsZ

Celebrating another great year of the #hepatitis clinic MD Anderson Cancer Center where more than 50 fellows from #infectious diseases and #gastroenterology/#hepatology have learned how to treat #viral hepatitis in #cancer patients IDSA AASLD BCM ID Fellowship @UT_infectious

New BCM ID Fellowship jackets have arrived! A huge thank you to our program for getting these for the fellows! Prathit Kulkarni, MD @MelanieGoebelMD

A Randomized, Double-Blind, Phase 3 Safety and Efficacy Study of Ridinilazole Versus Vancomycin for Treatment of Clostridioides difficile Infection: Clinical Outcomes With Microbiome and Metabolome Correlates of Response ✅ Just Accepted 🔓 Open Access bit.ly/49gqIeP

⁦BCM ID Fellowship⁩ trainees enjoying a well-deserved evening off after taking their in-training exam today. Extremely proud of this phenomenal crew!! ⁦Marilyne Daher⁩ ⁦@JesalShahMD⁩ ⁦@MelanieGoebelMD⁩

【IDSA Medical Education Community of Practice】 I'm truly honored to have been selected as a member of the Teaching & Learning Resources Working Group IDSA Medical Education Community of Practice IDSA! I'm excited to work on enhancing #IDMedEd and will give it my best effort! #IDFellow 1-min ID consult

In Memoriam: Dr. Barbara Murray at McGovern Medical School- deeply saddened by the loss of Dr. Murray. She was a tremendous mentor and dear friend who paved the way for many women leaders in Infectious Diseases. 🙏💜⁦@DrLuisO⁩ ⁦IDSA⁩ ⁦ med.uth.edu/blog/2024/04/1…

Estudio aleatorizado, doble-ciego, fase 3, para evaluar la seguridad y eficacia de ridinilazol (RDZ) vs. vancomicina (VAN) para el tratamiento de infección por Clostridioides difficile:respuesta clínica y efectos en el microbioma.

I am absolutely delighted☺️ to have the opportunity to meet and share thoughts with my fellow ✨Co-GME Senate Officers✨, who were recently appointed by MD Anderson Cancer Center🌟! It's truly inspiring to connect with such brilliant minds, all dedicated to making improvements, leading,

Inspiring the next generation of ID physicians at #IDWeek2024.

Congratulations to Pranita Tamma, MD, MHS, the recipient of IDSA’s 2024 Oswald Avery Award for Early Achievement. 🎉 Dr. Tamma of Johns Hopkins Medicine is an international leader in diagnosing and treating patients with gram-negative infections. Learn more: bit.ly/3UeL7Ml

A third year fellowship position in Transplant and Oncology Infectious Diseases is open at UT MD Anderson. Cutting edge cancer care, SCT, and CAR-T MD Anderson Cancer Center and SOT Texas Medical Center. Enjoy working with UTHealth Houston Infectious Diseases, BCM ID Fellowship and Houston Methodist. DM Pablo Okhuysen

TAILΦR Milestone! Dosed our first patient with Barbara Trautner in an academic-led clinical trial (NCT06559618). The phages were discovered, manufactured, tested, FDA approved and now administered in one location by one team, an end-to-end miracle we hope will counter the AMR crisis.